YaoGeJu

Company directoryChina company filings

Zein Biotechnology Co., Ltd.

As of 18 November 2026, for the company name Zein Biotechnology Co., Ltd. as recorded, the chemical-drug catalogue lists 17 active records with this name as holder; 35 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

31 acceptance records as first applicant, grouped into 15 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

琥珀酸地文拉法辛缓释片 · No verified English name 2 records · Latest accepted 2026/08/25

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602120Generic2026/08/25Zein Biotechnology Co., Ltd.CDE ↗
CYHS2602119Generic2026/08/25Zein Biotechnology Co., Ltd.CDE ↗
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2026/08/13

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602001Generic2026/08/13Zein Biotechnology Co., Ltd.CDE ↗
CYHS2201518Generic2022/09/14Zein Biotechnology Co., Ltd.CDE ↗
Ropinirole Hydrochloride Sustained-release Tablets 3 records · Latest accepted 2026/03/26

Supplement · 1Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600595Supplement2026/03/26Zein Biotechnology Co., Ltd.CDE ↗
CYHS2400315Generic2024/01/24Zein Biotechnology Co., Ltd.CDE ↗
CYHS2400314Generic2024/01/24Zein Biotechnology Co., Ltd.CDE ↗
Edoxaban Tosilate Tablets 3 records · Latest accepted 2026/02/06

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600395Generic2026/02/06Zein Biotechnology Co., Ltd.CDE ↗
CYHS2600394Generic2026/02/06Zein Biotechnology Co., Ltd.CDE ↗
CYHS2600393Generic2026/02/06Zein Biotechnology Co., Ltd.CDE ↗
Fexofenadine Hydrochloride Tablets 4 records · Latest accepted 2025/08/21

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503071Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗
CYHS2503070Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗
CYHS2503069Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗
CYHS2503068Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗
Voriconazole Tablets 2 records · Latest accepted 2025/07/17

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502561Generic2025/07/17Zein Biotechnology Co., Ltd.CDE ↗
CYHS2502560Generic2025/07/17Zein Biotechnology Co., Ltd.CDE ↗
Oseltamivir Phosphate Capsules 1 records · Latest accepted 2024/03/23

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400901Generic2024/03/23Zein Biotechnology Co., Ltd.CDE ↗
Pramipexole Dihydrochloride Tablets 2 records · Latest accepted 2024/01/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400102Generic2024/01/09Zein Biotechnology Co., Ltd.CDE ↗
CYHS2400101Generic2024/01/09Zein Biotechnology Co., Ltd.CDE ↗
Pramipexole Dihydrochloride Prolonged-release Tablets 2 records · Latest accepted 2023/10/25

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302880Generic2023/10/25Zein Biotechnology Co., Ltd.CDE ↗
CYHS2302878Generic2023/10/25Zein Biotechnology Co., Ltd.CDE ↗
Flupentixol and Melitracen Tablets 2 records · Latest accepted 2023/08/23

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302252Generic2023/08/23Zein Biotechnology Co., Ltd.CDE ↗
CYHS2202072Generic2022/12/16Zein Biotechnology Co., Ltd.CDE ↗
Sildenafil Citrate Tablets 3 records · Latest accepted 2023/05/24

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301398Generic2023/05/24Zein Biotechnology Co., Ltd.CDE ↗
CYHS2301397Generic2023/05/24Zein Biotechnology Co., Ltd.CDE ↗
CYHS2301396Generic2023/05/24Zein Biotechnology Co., Ltd.CDE ↗
Tadalafil Tablets 1 records · Latest accepted 2023/03/25

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2300617Supplement2023/03/25Zein Biotechnology Co., Ltd.CDE ↗
Orlistat Capsules 2 records · Latest accepted 2022/02/17

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250118Supplement2022/02/17Zein Biotechnology Co., Ltd.CDE ↗
CYHB2250117Supplement2022/02/17Zein Biotechnology Co., Ltd.CDE ↗
Rivaroxaban Tablets 1 records · Latest accepted 2022/02/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200270Generic2022/02/08Zein Biotechnology Co., Ltd.CDE ↗
阿柏西普眼内注射溶液 · No verified English name 1 records · Latest accepted 2022/01/05

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXSL2200003New drug2022/01/05Zein Biotechnology Co., Ltd.CDE ↗

Changes in the last 90 days

5 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 2 applicationsAccepted: 2 applicationsNotification delivery: 1 application

  1. 2026/11/03Marketing application approved

    Voriconazole Tablets

    CYHS2502561 · 国药准字H20266476

    Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06

    View source · Table row 97 ↗
  2. 2026/11/03Marketing application approved

    Voriconazole Tablets

    CYHS2502560 · 国药准字H20266475

    Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06

    View source · Table row 96 ↗
  3. 2026/10/28Notification delivery

    Dapoxetine Hydrochloride Tablets

    CYHS2602001

    Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Date added to this site: 2026/11/03

    Notification delivered; the specific outcome remains to be checked.

    View source · Table row 23 ↗
  4. 2026/08/25Accepted

    琥珀酸地文拉法辛缓释片 · No verified English name

    CYHS2602120

    Fact date: 2026/08/25 · Date added to this site: 2026/10/22

    View source ↗
  5. 2026/08/25Accepted

    琥珀酸地文拉法辛缓释片 · No verified English name

    CYHS2602119

    Fact date: 2026/08/25 · Date added to this site: 2026/10/22

    View source ↗

Under review

10 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
琥珀酸地文拉法辛缓释片 · No verified English name CYHS2602120Generic2026/08/25Zein Biotechnology Co., Ltd.CDE ↗
琥珀酸地文拉法辛缓释片 · No verified English name CYHS2602119Generic2026/08/25Zein Biotechnology Co., Ltd.CDE ↗
Ropinirole Hydrochloride Sustained-release Tablets CYHB2600595Supplement2026/03/26Zein Biotechnology Co., Ltd.CDE ↗
Edoxaban Tosilate Tablets CYHS2600395Generic2026/02/06Zein Biotechnology Co., Ltd.CDE ↗
Edoxaban Tosilate Tablets CYHS2600394Generic2026/02/06Zein Biotechnology Co., Ltd.CDE ↗
Edoxaban Tosilate Tablets CYHS2600393Generic2026/02/06Zein Biotechnology Co., Ltd.CDE ↗
Fexofenadine Hydrochloride Tablets CYHS2503071Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗
Fexofenadine Hydrochloride Tablets CYHS2503070Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗
Fexofenadine Hydrochloride Tablets CYHS2503069Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗
Fexofenadine Hydrochloride Tablets CYHS2503068Generic2025/08/21Zein Biotechnology Co., Ltd.CDE ↗

Catalogue holder records

17 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Pramipexole Dihydrochloride TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202542322025/05/20Not stated by sourceCDE ↗
Pramipexole Dihydrochloride TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202542332025/05/20Generic approved under the new chemical-drug registration classificationCDE ↗
Ropinirole Hydrochloride Sustained-release TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202538172025/04/08Generic approved under the new chemical-drug registration classificationCDE ↗
Pramipexole Dihydrochloride Prolonged-release TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202536862025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Pramipexole Dihydrochloride Prolonged-release TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202536872025/03/25Generic approved under the new chemical-drug registration classificationCDE ↗
Oseltamivir Phosphate CapsulesZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202531232025/01/08Generic approved under the new chemical-drug registration classificationCDE ↗
Flupentixol and Melitracen TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202491602024/10/22Generic approved under the new chemical-drug registration classificationCDE ↗
Sildenafil Citrate TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202446952024/08/20Generic approved under the new chemical-drug registration classificationCDE ↗
Sildenafil Citrate TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202446962024/08/20Generic approved under the new chemical-drug registration classificationCDE ↗
Sildenafil Citrate TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202446972024/08/20Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202470842024/04/23Generic approved under the new chemical-drug registration classificationCDE ↗
Rivaroxaban TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202341432023/09/12Generic approved under the new chemical-drug registration classificationCDE ↗
Orlistat CapsulesZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H201331712023/05/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Orlistat CapsulesZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H201231312023/05/24Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tadalafil TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H202231012022/03/01Generic approved under the new chemical-drug registration classificationCDE ↗
Ropinirole Hydrochloride TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H201300452022/01/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ropinirole Hydrochloride TabletsZein Biotechnology Co., Ltd.Zein Biotechnology Co., Ltd.国药准字H201300442022/01/04Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

35 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
伏格列波糖 · No verified English nameZein Biotechnology Co., Ltd.Y20260000626I2026/08/07CDE ↗
亚甲蓝 · No verified English nameZein Biotechnology Co., Ltd.Y20260000570I2026/07/31CDE ↗
伊班膦酸钠 · No verified English nameZein Biotechnology Co., Ltd.Y20260000393I2026/06/04CDE ↗
盐酸氯普鲁卡因 · No verified English nameZein Biotechnology Co., Ltd.Y20260000278I2026/05/12CDE ↗
马来酸左氨氯地平 · No verified English nameZein Biotechnology Co., Ltd.Y20250001196I2025/12/02CDE ↗
重酒石酸去甲肾上腺素 · No verified English nameZein Biotechnology Co., Ltd.Y20250001057I2025/10/15CDE ↗
盐酸齐拉西酮 · No verified English nameZein Biotechnology Co., Ltd.Y20250000981I2025/09/11CDE ↗
盐酸乙哌立松 · No verified English nameZein Biotechnology Co., Ltd.Y20250000383A2026/11/13CDE ↗
盐酸曲唑酮 · No verified English nameZein Biotechnology Co., Ltd.Y20250000281I2025/03/26CDE ↗
布立西坦 · No verified English nameZein Biotechnology Co., Ltd.Y20240001550I2025/01/13CDE ↗
无水乙醇 · No verified English nameZein Biotechnology Co., Ltd.Y20240001251A2026/04/29CDE ↗
伏立康唑 · No verified English nameZein Biotechnology Co., Ltd.Y20240000547A2025/11/14CDE ↗
富马酸单甲酯 · No verified English nameZein Biotechnology Co., Ltd.Y20230001093I2024/03/11CDE ↗
帕拉米韦 · No verified English nameZein Biotechnology Co., Ltd.Y20230001127A2026/08/22CDE ↗
甲苯磺酸艾多沙班 · No verified English nameZein Biotechnology Co., Ltd.Y20240000002A2025/05/28CDE ↗
盐酸美利曲辛 · No verified English nameZein Biotechnology Co., Ltd.Y20230000670A2026/02/14CDE ↗
达格列净 · No verified English nameZein Biotechnology Co., Ltd.Y20230000618A2026/06/04CDE ↗
琥珀酸地文拉法辛 · No verified English nameZein Biotechnology Co., Ltd.Y20230000468A2026/07/25CDE ↗
盐酸托莫西汀 · No verified English nameZein Biotechnology Co., Ltd.Y20230000127A2024/09/25CDE ↗
拉考沙胺 · No verified English nameZein Biotechnology Co., Ltd.Y20230000125A2024/10/25CDE ↗
他达拉非 · No verified English nameZein Biotechnology Co., Ltd.Y20230000048A2025/12/17CDE ↗
硫酸钾 · No verified English nameZein Biotechnology Co., Ltd.Y20220001220A2024/06/05CDE ↗
枸橼酸苯海拉明 · No verified English nameZein Biotechnology Co., Ltd.Y20220001232A2026/02/26CDE ↗
罗格列酮钠 · No verified English nameZein Biotechnology Co., Ltd.Y20220001267A2024/05/22CDE ↗
盐酸依匹斯汀 · No verified English nameZein Biotechnology Co., Ltd.Y20220001174A2024/07/09CDE ↗
盐酸美金刚 · No verified English nameZein Biotechnology Co., Ltd.Y20220000214A2023/12/05CDE ↗
盐酸氟哌噻吨 · No verified English nameZein Biotechnology Co., Ltd.Y20210001166A2023/07/24CDE ↗
利伐沙班 · No verified English nameZein Biotechnology Co., Ltd.Y20210001063A2025/04/16CDE ↗
硫酸特布他林 · No verified English nameZein Biotechnology Co., Ltd.Y20210000916A2026/03/21CDE ↗
盐酸美利曲辛 · No verified English nameZein Biotechnology Co., Ltd.Y20210000944I2023/06/28CDE ↗
盐酸罗匹尼罗 · No verified English nameZein Biotechnology Co., Ltd.Y20190007181A—CDE ↗
甲磺司特 · No verified English nameZein Biotechnology Co., Ltd.Y20190006952A2024/07/23CDE ↗
盐酸托烷司琼 · No verified English nameZein Biotechnology Co., Ltd.Y20190006006A2025/10/22CDE ↗
盐酸多奈哌齐 · No verified English nameZein Biotechnology Co., Ltd.Y20190005502A2025/07/04CDE ↗
奥利司他 · No verified English nameZein Biotechnology Co., Ltd.Y20190002310A2025/08/16CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

32 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Metformin Hydrochloride Extended-release Tablets CYHB2601858Supplement2026/10/10Chongqing Xing Chuang Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Acetylcysteine Tablets CYHS2600860Generic2026/04/15Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Eperisone Hydrochloride Tablets CYHS2600582Generic2026/02/28Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Ziprasidone Hydrochloride Capsules CYHS2600263Generic2026/01/23Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Ziprasidone Hydrochloride Capsules CYHS2600262Generic2026/01/23Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Acetylcysteine Tablets CYHS2600151Generic2026/01/13Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
马来酸左氨氯地平片 · No verified English name CYHS2504318Generic2025/12/19Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2503230Generic2025/09/02Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2503229Generic2025/09/02Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2503228Generic2025/09/02Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Trazodone Hydrochloride Sustained-release Tablets CYHS2503145Generic2025/08/27Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Trazodone Hydrochloride Sustained-release Tablets CYHS2503144Generic2025/08/27Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Levodopa and Benserazide Hydrochloride Tablets CYHS2500784Generic2025/02/18Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
LJ01003 · No verified English name CXHS2500009New drug2025/01/21Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
LJ01003 · No verified English name CXHS2500008New drug2025/01/21Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Rivaroxaban Tablets CYHB2402256Supplement2024/12/31Chongqing Xing Chuang Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Vonoprazan Fumarate Tablets CYHS2403646Generic2024/10/26Chengdu Qin Run Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Vonoprazan Fumarate Tablets CYHS2403645Generic2024/10/26Chengdu Qin Run Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
甲磺司特颗粒 · No verified English name CYHB2450431Supplement2024/08/13Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
甲磺司特颗粒 · No verified English name CYHB2450430Supplement2024/08/13Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
甲磺司特颗粒 · No verified English name CYHB2450429Supplement2024/08/13Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
枸橼酸苯海拉明布洛芬片 · No verified English name CYHS2401813Generic2024/06/18Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Rivaroxaban Tablets CYHB2400417Supplement2024/03/25Chongqing Xing Chuang Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Paracetamol and Ibuprofen Tablets CYHS2303092Generic2023/11/10Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
甲磺司特颗粒 · No verified English name CYHB2301054Supplement2023/05/13Chongqing En Chuang Medical Management Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
LJ01003 · No verified English name CXHS2300046New drug2023/04/18Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
LJ01003 · No verified English name CXHS2300045New drug2023/04/18Changchun Lan Jiang Pharmaceuticals Technology Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Ropinirole Hydrochloride Tablets CYHB2300646Supplement2023/03/30Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Ropinirole Hydrochloride Tablets CYHB2300645Supplement2023/03/30Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Trimetazidine Dihydrochloride Tablets CYHB2300644Supplement2023/03/30Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Trimetazidine Dihydrochloride Tablets CYHB2300643Supplement2023/03/30Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗
Trimetazidine Dihydrochloride Tablets CYHB2340008Supplement2023/02/09Chongqing Rui En Pharmaceuticals Co., Ltd. romanized; Zein Biotechnology Co., Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.